PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-29

  1. 111 Posts.
    lightbulb Created with Sketch. 29
    What did people expect? we came in under guidance. Were people expecting that somehow our cash on hand had increased thoughout the quarter?
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.